State of the Art in Idiopathic Pulmonary Fibrosis

This reprint is a compilation of ten publications, including original-research and review articles, and the accompanying editorial within the scope of a Special Issue entitled: "State of the Art in Idiopathic Pulmonary Fibrosis" published in Cells.

Gespeichert in:

Bibliographische Detailangaben
Format:	Buch
Sprache:	eng
Schlagworte:	(pan-)HDAC-inhibitor 3D cultures adverse event airway epithelium alveolar epithelial cells alveolar epithelial progenitors alveolar fibroelastosis amphiregulin antibody folding antifibrotic treatment AT2 cells basal cells bleomycin bleomycin-induced pulmonary fibrosis body mass index Book Industry Communication bronchial epithelium bronchiolar basal cells bronchiolization CD24 CK5 Class I-HDAC-inhibitor discontinuation drug screening epidermal growth factor epidermal growth factor receptor epithelial populations ER stress ErbB-signaling fibroblast-to-myofibroblast differentiation (FMD) FK506-binding protein flow cytometry histone acetylation histone deacetylase (HDAC) idiopathic pulmonary fibrosis idiopathic pulmonary fibrosis (IPF) IGF1 IGF1R immunophilin intermediate epithelial cells interstitial fibrosis interstitial lung disease IPF IPF modelling lung lung development lung fibrosis lung transcriptomic profile LysoTracker Medicine MUC5B n/a neuregulin 1 NGFR nintedanib non-histone protein acetylation peptidyl-prolyl isomerase pirfenidone pulmonary fibrosis recombinant FGF10 single cell RNA sequencing tacrolimus TGF-α TGF-β transitional states type-II alveolar epithelial cell (AECII) tyrosine kinase inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!